[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Biomaven Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::111029613.png) Peter Suzman [@Biomaven](/creator/twitter/Biomaven) on x 8520 followers
Created: 2020-10-16 18:50:21 UTC

$QURE weakness on partnering their key asset reminds me a bit of $PCYC weakness (stock fell to low teens if I recall correctly on dashed hopes for merger) shortly after partnered ibrutinib with $JNJ 
The success of the drug led to them being taken out for $XXX a few years later.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1317176068927856640/c:line.svg)

**Related Topics**
[jnj](/topic/jnj)
[$jnj](/topic/$jnj)
[corporate finance](/topic/corporate-finance)
[alternative investment](/topic/alternative-investment)
[$pcyc](/topic/$pcyc)
[$qure](/topic/$qure)
[johnson johnson](/topic/johnson-johnson)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Biomaven/status/1317176068927856640)